This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Endoh, Y. Articles by Motoyama, T. Search for Related Content PubMed PubMed Citation Articles by Endoh, Y. Articles by Motoyama, T.

(American Journal of Pathology. 2000;157:717-722.)
© 2000 American Society for Investigative Pathology

Short Communications

Frequent Hypermethylation of the hMLH1 Gene Promoter in Differentiated-Type Tumors of the Stomach with the Gastric Foveolar Phenotype

Yasushi Endoh^*, Gen Tamura^*, Yoichi Ajioka, Hidenobu Watanabe and Teiichi Motoyama^*

From the Department of Pathology,^* Yamagata UniversitySchool of Medicine, Yamagata; and the Department ofPathology, Niigata University School ofMedicine, Niigata, Japan

Hypermethylation of the hMLH1 mismatch repair gene promoter has been revealed to lead to microsatellite instability (MSI). Previously, we demonstrated a high prevalence of MSI in differentiated-type gastric tumors showing distinct features of gastric foveolar epithelium (foveolar type). To clarify the significance of hMLH1 promoter hypermethylation in the development of this tumor type, we studied promoter methylation status and expression of hMLH1 in foveolar-type tumors and their surrounding non-neoplastic mucosae, as well as in tumors with other cellular phenotypes. The results were compared to MSI status. After phenotypical analyses using mucin histochemistry and immunohistochemistry, 41 differentiated-type tumors with distinct cellular phenotypes were classified into three categories: foveolar type, intestinal type (tumors with the distinct cellular phenotype of the intestine), and combined type (tumors with both foveolar and intestinal phenotypes). Methylation-specific polymerase chain reaction (MSP) was performed to determine the methylation status of hMLH1 promoter. hMLH1 protein expression was immunohistochemically examined. MSI was detected in 57% of the foveolar type, 8% of the intestinal type, and 67% of the combined-type tumors. Hypermethylation of hMLH1 promoter was found in 74% of the foveolar type, 33% of the intestinal type, and 83% of the combined-type tumors. Of 18 MSI-positive tumors, all but one were hypermethylated. Methylation status of hMLH1 promoter correlated well with protein expression in foveolar-type tumors. Moreover, hypermethylation was also detected frequently (71%) in the non-neoplastic surrounding mucosa of the hypermethylated tumors. Hypermethylation of hMLH1 promoter is an initial, vital event in the development of foveolar-type tumors of the stomach.

This article has been cited by other articles:

				T. Honda, G. Tamura, Y. Endoh, S. Nishizuka, S. Kawata, and T. Motoyama Expression of Tumor Suppressor and Tumor-related Proteins in Differentiated Carcinoma, Undifferentiated Carcinoma with Tubular Component and Pure Undifferentiated Carcinoma of the Stomach Jpn. J. Clin. Oncol., October 1, 2005; 35(10): 580 - 586. [Abstract] [Full Text] [PDF]

				T. Etoh, Y. Kanai, S. Ushijima, T. Nakagawa, Y. Nakanishi, M. Sasako, S. Kitano, and S. Hirohashi Increased DNA Methyltransferase 1 (DNMT1) Protein Expression Correlates Significantly with Poorer Tumor Differentiation and Frequent DNA Hypermethylation of Multiple CpG Islands in Gastric Cancers Am. J. Pathol., February 1, 2004; 164(2): 689 - 699. [Abstract] [Full Text] [PDF]

				T. Waki, G. Tamura, T. Tsuchiya, K. Sato, S. Nishizuka, and T. Motoyama Promoter Methylation Status of E-Cadherin, hMLH1, and p16 Genes in Nonneoplastic Gastric Epithelia Am. J. Pathol., August 1, 2002; 161(2): 399 - 403. [Abstract] [Full Text] [PDF]